BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1360820)

  • 41. Association between P-glycoprotein and lymphoid antigen expression on myeloblasts versus therapy response and survival in de novo acute myeloid leukemia: long-term follow-up results.
    Machaczka M; Wahlin BE; Piatkowska-Jakubas B; Rucinska M; Jurczak W; Balana-Nowak A; Klimkowska M; Hägglund H; Skotnicki AB
    Med Oncol; 2012 Sep; 29(3):2070-6. PubMed ID: 21861206
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation of P-glycoprotein expression and function in childhood acute leukemia: a children's cancer group study.
    Ivy SP; Olshefski RS; Taylor BJ; Patel KM; Reaman GH
    Blood; 1996 Jul; 88(1):309-18. PubMed ID: 8704189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
    Stein U; Walther W; Shoemaker RH
    J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Verapamil and cyclosporin A potentiate the effects of chemotherapeutic drugs in the human medullary thyroid carcinoma TT cell line not expressing the 170 kDa P-glycoprotein.
    Larsson R; Nygren P
    Cancer Lett; 1990 Nov; 54(3):125-31. PubMed ID: 1977512
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Verapamil reversal of vincristine resistance and cross-resistance patterns of vincristine-resistant Chinese hamster ovary cells.
    Brewer F; Warr JR
    Cancer Treat Rep; 1987 Apr; 71(4):353-9. PubMed ID: 2881620
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Idarubicin overcomes P-glycoprotein-related multidrug resistance: comparison with doxorubicin and daunorubicin in human multiple myeloma cell lines.
    Roovers DJ; van Vliet M; Bloem AC; Lokhorst HM
    Leuk Res; 1999 Jun; 23(6):539-48. PubMed ID: 10374847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical modulation of multidrug resistance in multiple myeloma: effect of cyclosporine on resistant tumor cells.
    Sonneveld P; Schoester M; de Leeuw K
    J Clin Oncol; 1994 Aug; 12(8):1584-91. PubMed ID: 7518859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Idarubicin monotherapy in multiply pretreated leukemia patients: response in relation to P-glycoprotein expression.
    Nüssler V; Gieseler F; Zwierzina H; Gullis E; Pelka-Fleischer R; Diem H; Abenhardt W; Schmitt R; Langenmayer I; Wohlrab A; Kolb HJ; Wilmanns W
    Ann Hematol; 1997 Feb; 74(2):57-64. PubMed ID: 9063374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia.
    Pieters R; Hongo T; Loonen AH; Huismans DR; Broxterman HJ; Hählen K; Veerman AJ
    Br J Cancer; 1992 May; 65(5):691-7. PubMed ID: 1350207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia.
    Ma P; Dong X; Swadley CL; Gupte A; Leggas M; Ledebur HC; Mumper RJ
    J Biomed Nanotechnol; 2009 Apr; 5(2):151-61. PubMed ID: 20055093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liposome-mediated modulation of multidrug resistance in human HL-60 leukemia cells.
    Rahman A; Husain SR; Siddiqui J; Verma M; Agresti M; Center M; Safa AR; Glazer RI
    J Natl Cancer Inst; 1992 Dec; 84(24):1909-15. PubMed ID: 1361008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multidrug resistant HOB1 lymphoma cells express P-glycoprotein that does not play the major role in the development of drug resistance to adriamycin.
    Lee WP; Lee CL; Kao MC
    Biochem Biophys Res Commun; 1992 Nov; 189(1):92-100. PubMed ID: 1360209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Verapamil decreases P-glycoprotein expression in multidrug-resistant human leukemic cell lines.
    Muller C; Bailly JD; Goubin F; Laredo J; Jaffrézou JP; Bordier C; Laurent G
    Int J Cancer; 1994 Mar; 56(5):749-54. PubMed ID: 7906257
    [TBL] [Abstract][Full Text] [Related]  

  • 54. P-glycoprotein and alterations in the glutathione/glutathione-peroxidase cycle underlie doxorubicin resistance in HL-60-R, a subclone of the HL-60 human leukemia cell line.
    Raghu G; Pierre-Jerome M; Dordal MS; Simonian P; Bauer KD; Winter JN
    Int J Cancer; 1993 Mar; 53(5):804-11. PubMed ID: 8095491
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation between functional and molecular analysis of mdr1 P-glycoprotein in human solid-tumor xenografts.
    Broxterman HJ; Feller N; Kuiper CM; Boven E; Versantvoort CH; Teerlink T; Pinedo HM; Lankelma J
    Int J Cancer; 1995 Jun; 61(6):880-6. PubMed ID: 7790125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia.
    Schuurhuis GJ; Broxterman HJ; Ossenkoppele GJ; Baak JP; Eekman CA; Kuiper CM; Feller N; van Heijningen TH; Klumper E; Pieters R
    Clin Cancer Res; 1995 Jan; 1(1):81-93. PubMed ID: 9815890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prolongation of medium exchange is associated with a decrease in function but not expression of the P-glycoprotein pump in leukaemic cells.
    Hegewisch-Becker S; Faltz C; Hossfeld DK
    Eur J Haematol; 1996; 56(1-2):12-22. PubMed ID: 8599988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Daunorubicin (DNR) accumulation in fresh leukemic cells: correlation with clinical and biological features.
    Boiron JM; Belloc F; Montastruc M; Cony-Makhoul P; Marit G; Puntous M; Dumain P; Lacombe F; Dubosc-Marchenay N; Fabères C
    Leuk Lymphoma; 1994 Apr; 13(3-4):291-6. PubMed ID: 8049651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A lack of adriamycin (ADR) resistance in Chinese hamster ovary (CHO) cells overexpressing P-glycoprotein (Pgp) following in vitro exposure to fractionated X-irradiation.
    Whelan RD; Hosking LK; Hill BT
    Biochem Soc Trans; 1991 Apr; 19(2):125S. PubMed ID: 1679723
    [No Abstract]   [Full Text] [Related]  

  • 60. Influence of serum protein binding on the uptake and retention of idarubicin by sensitive and multidrug resistant human leukemic cells.
    Kessel M; Gieseler F; Woodcock BG
    Eur J Clin Pharmacol; 1999 Jul; 55(5):369-73. PubMed ID: 10456486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.